RESMED INC — Director's Dealing 2010

Dec 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-12-17

Reporting Person: Gallahue Kieran (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-17	ResMed Common Stock	M	20000	$21.025	Acquired	76921.794	Direct
2010-12-17	ResMed Common Stock	S	20000	$35.00	Disposed	56921.794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-12-17	ResMed Common Stock Options	$21.025	M	20000	Disposed	2014-11-07	ResMed Common Stock (20000)	Direct

Footnotes

F1: Represents first date options became exercisable.